Working at Genmab
You have the chance to join an international biotech company at the verge of launching several groundbreaking biomedical products with the potential to make a true and global impact.

Within the coming years, Genmab will complete Phase III for 3 antibody-based products to be used in the treatment of cutaneous T-cell lymphoma, head and neck cancer and non-Hodgkin's lymphoma/chronic lymphocytic leukemia.  We expect to be ready to launch HuMax-CD4® (zanolimumab), HuMax-CD20™ (ofatumumab) and HuMax-EGFr™(zalutumumab) within a couple years.

At Genmab, you will work in project teams across international sites and specialized functions, sharing knowledge to fast track and perfect our product development.  This means you will have the opportunity to acquire knowledge outside your specialist function and gain broad insight into the entire clinical development process.  As Genmab is still a relatively small organization, we are characterized by an informal and flexible working environment, providing you with excellent possibilities for direct influence, personal and professional developmet as well as a great work-life balance.